← Leaderboards
Jerry Saul Wolinsky
University Of Texas Hlth Sci Ctr Houston
$26,242
Attributed
$26,242
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$26,242 · 2
By mechanism
M01$26,242 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Sandeep K Agarwal$3,522,043
- Sudhir Paul$10,174,455
- Kazim A Sheikh$11,409,209
- Ponnada A Narayana$19,017,319
- John Duffin Reveille$11,528,689
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationMultiple SclerosisDrug Screening /EvaluationClinical ResearchMagnetic Resonance ImagingPlacebosDrug Administration Rate /DurationDrug Administration RoutesGadoliniumInterferon BetaNervous System Disorder ChemotherapyOutcomes ResearchPathologic ProcessHormone TherapyMethylprednisoloneMonoclonal AntibodyImmunotherapy
Grant awards (4)
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS$0
M01 · FY2002 · RR
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS$0
M01 · FY2001 · RR
HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS$15,114
M01 · FY2000 · RR
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS$11,128
M01 · FY2000 · RR